#CHINA . El TRATAMIENTO #SMALL_CELL_LUNG_CANCER Primera Linea #Serplulimab Más #Quimioterapia No es una Estrategia Rentable A PESAR DE SER LA MEJOR...¡TOCARA REALIZAR UN DESCUENTO DEL PRECIO!... Así es CHINA y lo Hace con una Farmacéutica CHINA. https://t.
1,523 followers
5,127 followers
New Research: Cost-effectiveness analysis of first-line serplulimab combined with chemotherapy for extensive-stage small cell lung cancer: Background For patients with extensive-stage small cell lung cancer (ES-SCLC),… #PublicHealth #HealthForAll https://
438 followers
Cost-effectiveness analysis of first-line serplulimab combined with chemotherapy for extensive-stage small cell lung cancer https://t.co/RbCn6ag7DR @ulkubulut111